Rosetta Genomics Ltd. (USA) (NASDAQ:ROSG)
CAPS Rating:
The Company is seeking to develop and commercialize new diagnostic and therapeutic products based on a recently discovered group of genes known as microRNAs.
The Company is seeking to develop and commercialize new diagnostic and therapeutic products based on a recently discovered group of genes known as microRNAs.
Recs
dump on any sign of strength